Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 11/20 | 0.52 |
| ▸ | ESR1 | P03372 | 8/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | HTR6 | P50406 | 1/20 | 0.34 |
| ▸ | ESRRG | P62508 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ENTPD5 | O75356 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9803643 | 0.86 | ESR2 (0.50) | ESR2ESR1HSD17B10CYP3A4AR | |
| SCHEMBL9066174 | 0.85 | ESR2 (0.46) | ESR2ESR1HSD17B10CYP3A4AR | |
| SCHEMBL9066161 | 0.84 | ESR2 (0.45) | ESR2ESR1HSD17B10CYP3A4AR | |
| SCHEMBL9803912 | 0.83 | ESR2 (0.44) | ESR2ESR1CYP3A4OPRM1OPRK1 | |
| SCHEMBL9066130 | 0.83 | ESR2 (0.44) | ESR2ESR1HSD11B1OPRM1OPRK1 | |
| SCHEMBL6451587 | 0.83 | ESR1 (0.47) | ESR2ESR1HSD17B10CYP3A4AR | |
| SCHEMBL9066376 | 0.81 | ESR1 (0.60) | ESR2ESR1AROPRM1OPRK1 | |
| SCHEMBL23250802 | 0.80 | ESR2 (0.46) | ESR2ESR1HSD17B10CYP3A4AR | |
| SCHEMBL8959239 | 0.80 | ESR1 (0.45) | ESR2ESR1HSD17B10CYP3A4AR | |
| SCHEMBL2498416 | 0.80 | ESR2 (0.53) | ESR2ESR1HSD17B10CYP3A4AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3489303-B1 | POLYCARBONATE RESIN COMPOSITION | MITSUBISHI ENG PLASTICS CORP (JP) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026100594-A1 | POLYCARBONATE RESIN COMPOSITION | 三菱エンジニアリングプラスチックス株式会社 | 2026-05-15 | — | — | WO | disclosed |
| WO-2026100197-A1 | POLYCARBONATE RESIN COMPOSITION | 三菱エンジニアリングプラスチックス株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-20260125537-A1 | POLYCARBONATE RESIN COMPOSITION | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2026-05-07 | — | — | US | disclosed |
| EP-4692233-A1 | POLYCARBONATE RESIN COMPOSITION | Mitsubishi Engineering-Plastics Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260015500-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2026-01-15 | — | — | US | disclosed |
| EP-4674907-A1 | RESIN COMPOSITION AND RESIN MOLDED ARTICLE | Konica Minolta, Inc. (JP) | 2026-01-07 | — | — | EP | disclosed |
| US-12460048-B2 | Thermoplastic resin composition and formed product | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-11-04 | — | — | US | disclosed |
| EP-4596628-A1 | POLYCARBONATE RESIN COMPOSITION | Mitsubishi Engineering-Plastics Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| EP-4563655-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE | Mitsubishi Engineering-Plastics Corporation (JP) | 2025-06-04 | — | — | EP | disclosed |
| EP-0469403-B1 | High molecular weight polyester based on 1,1-bis-(4-hydroxyphenyl)-alkylcycloalkanes and thermoplastic blends thereof | BAYER AG (DE) | 1996-02-28 | — | — | EP | disclosed |
| EP-0481287-B1 | Method for the production of substituted cyclohexylidenebisphenols | BAYER AG (DE) | 1996-01-17 | — | — | EP | disclosed |
| EP-0374656-B1 | POLYCARBONATES FROM ALKYL CYCLOHEXYLIDENE DIPHENOLS | BAYER AG (DE) | 1993-03-17 | — | — | EP | disclosed |
| EP-0481287-A2 | Method for the production of substituted cyclohexylidenebisphenols | BAYER AG (DE) | 1992-04-22 | — | — | EP | disclosed |
| EP-0469404-A2 | Polyestercarbonates based on 1,1-bis-(4-hydroxyphenyl)-alkylcycloalkanes and thermoplastic blends thereof | BAYER AG (DE) | 1992-02-05 | — | — | EP | disclosed |
| EP-0469403-A2 | High molecular weight polyester based on 1,1-bis-(4-hydroxyphenyl)-alkylcycloalkanes and thermoplastic blends thereof | BAYER AG (DE) | 1992-02-05 | — | — | EP | disclosed |
| US-5034457-A | Polycarbonate for use in molding materials for laminated films and for electronics | BAYER AKTIENGESELLSCHAFT (DE) | 1991-07-23 | — | — | US | disclosed |
| US-5010162-A | Polycarbonate of alkyl cyclohexylidene bisphenol | BAYER AKTIENGESELLSCHAFT (DE) | 1991-04-23 | — | — | US | disclosed |
| EP-0387593-A2 | Thermoplastic alloys of polycarbonates based on substituted cyclohexylidenbisphenols | BAYER AG (DE) | 1990-09-19 | — | — | EP | disclosed |
| EP-0374656-A2 | Polycarbonates from alkyl cyclohexylidene diphenols | BAYER AG (DE) | 1990-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125537-A1 | POLYCARBONATE RESIN COMPOSITION | COL1A1, RER1, GSTP1 | ESR2 550/4885ESR1 990/4885HSD17B10 873/4885 |
| US-20260015500-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE | CHERP, RER1, TAF1 | ESR2 861/4885ESR1 602/4885HSD17B10 3555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.